J-Gaba CR Sustained Release Tablet 75mg (Pregabalin)

Adult dosage

This medication is taken once daily after dinner. It must be swallowed whole and should not be split, crushed, or chewed. The initial dose may be 150 mg once daily. Depending on the patient’s response and tolerance, the dosage may be increased up to a maximum of 600 mg once daily at weekly intervals. Patients with impaired kidney function should have their dosage adjusted according to creatinine clearance (CLcr). CLcr ≥60 mL/

Children's dosage

The safety and efficacy in pediatric and adolescent patients under 19 years of age have not been established.

This medication may increase the risk of suicidal thoughts or behaviors, so you must immediately inform healthcare personnel if you experience mood changes or symptoms of depression during treatment. Patients with an allergy to any ingredient in this medication should not take it. Diabetic patients may experience weight gain from this medication and may need to adjust the dosage of blood sugar control medications. If allergic reactions such as angioedema occur, discontinue the medication immediately and consult your healthcare provider. Elderly patients may have an increased risk of injury from dizziness or drowsiness caused by this medication, so caution is advised. Blurry vision or changes in vision may occur, and these symptoms may improve after discontinuation of the medication. Abrupt discontinuation of this medication can result in withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually in consultation with healthcare personnel. Due to the risk of drug abuse, patients with a history of substance abuse should exercise particular caution when taking this medication. Patients with impaired kidney function may require dosage adjustments. Patients with heart disease should consult healthcare personnel before taking this medication. Caution is required when taking this medication in combination with opioid analgesics as it may increase the risk of central nervous system depression. There may be a serious risk of respiratory depression in patients with respiratory or neurological disorders, renal impairment, and the elderly, so dosage adjustments may be necessary. During early pregnancy, there is a risk of fetal malformation, so women who are pregnant or planning to become pregnant must consult healthcare personnel before taking this medication and use effective contraception. This medication may cause dizziness and drowsiness, so caution is advised when driving or operating dangerous machinery. Severe skin reactions may occur rarely, so if any unusual symptoms like skin rash or swelling appear, discontinue the medication immediately and inform your healthcare provider. This medication has minimal pharmacokinetic interactions with other drugs; however, caution is advised when taken with alcohol or central nervous system depressants, as it may enhance effects and increase side effect risks. Women who are breastfeeding should consult healthcare personnel since this medication may be excreted in breast milk and consider whether to discontinue breastfeeding or the medication. In case of overdose, symptoms such as drowsiness, confusion, and seizures may occur, and immediate medical attention is required.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Dizziness
• drowsiness
• headache
• lethargy
• somnolence
• constipation
• dyspepsia
• nausea
• dry mouth
• vomiting

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius to help preserve the efficacy and safety of the medication over time.

Appearance

This medication is a white to light yellow rectangular film-coated sustained release tripe tablet.

Package unit

30 tablets/box [(6 tablets/PTP x 5)]